缺血性心脏病

quē xuè xìnɡ xīn zànɡ bìnɡ
  • ischemic heart disease
缺血性心脏病缺血性心脏病
  1. 白细胞介素-18高敏C反应蛋白与缺血性心脏病心衰关系的研究

    Relationship between Interleukin-18 High Sensitivity C-reactive Protein and Heart Failure Due to Ischemic Heart Disease

  2. 缺血性心脏病多层螺旋CT心肌灌注成像的实验和临床研究

    Experimental and Clinical Study of Myocardial Perfusion by MSCT : Characterization of Ischemic Heart Disease

  3. U波异常对缺血性心脏病的诊断价值探讨

    Abnormal U waves in the diagnosis of the ischemic myocardial disease

  4. ATP负荷MR心肌灌注成像对缺血性心脏病心肌血流储备的评价

    Myocardial flow reserve in ischemic heart diseases : assessment with MR myocardial perfusion imaging and ATP stress

  5. 目的探讨U波异常在诊断缺血性心脏病中的价值。

    Objective To study the diagnostic significance of abnormal U waves in the ischemic heart disease .

  6. U波异常有助诊断缺血性心脏病-冠脉造影与心电图对照

    Abnormal U Waves in the Diagnosis of the Ischemic Heart Disease-Comparison between Coronary Arteriography and EKG

  7. 死亡病例年龄中位数:脑血管病为72.07岁,缺血性心脏病为68.28岁,二者有显著性差异(P<0.05)。

    ( P < 0.01 ) . The median ages of the dead cases of the cerebrovascular diseases and ischemic heart diseases were 72.07 and 68.28 respectively .

  8. 冠心病是以动脉粥样硬化为基本病变,继而引起冠脉管腔狭窄的缺血性心脏病(Ischemicheartdisease)。

    Coronary heart disease is also called ischemic heart disease , the basic pathologic changes of which are atherosclerosis inducing coronary artery to stenosis severity .

  9. 运动对缺血性心脏病QT离散度的影响

    Influence of Exercise on QT Dispersion in Ischemic Heart Disease

  10. 辛伐他丁对缺血性心脏病伴原发性高胆固醇血症患者NO、ET、Tc浓度的影响

    Simvastatin on the effect of the concentrations of NO , ET & Tc in the ischemia cardiopathy with hypercholesterolemia

  11. 甘油三酯、低密度脂蛋白、缺血性心脏病、闭塞性动脉硬化和视网膜病变是影响血清VEGF水平的危险因素。

    Triglyceride , LDL , ischemic heart disease , arteriosclerosis obliterans and diabetic retinopathy were risk factors of serum VEGF level .

  12. 目的:急性冠状动脉综合征(acutecoronarysyndrome,ACS)是在冠状动脉粥样硬化斑块破裂基础上合并血栓形成而引起的一组严重的急性缺血性心脏病,血栓形成是其重要病理改变。

    Objective : Acute coronary syndrome ( ACS ) is a kind of acute severe ischemic heart disease due to thrombus formation after plaque rupture .

  13. 转染VEGF基因的骨骼肌成肌细胞移植结合左心室成形术治疗缺血性心脏病晚期充血性心力衰竭的实验研究

    An Experimental Study of Transplantation of Skeletal Myoblasts Transfected by VEGF Gene Combined with Left Ventricular Repair Surgery on Ischemic Congestive Heart Failure

  14. FD是传统的中药制剂,临床上主要用于缺血性心脏病的治疗。

    FD is a commonly used traditional Chinese medecine and is applied to ischemic heart disease .

  15. 转染ANG及转染VEGF基因的自体骨髓间充质干细胞移植治疗慢性缺血性心脏病的实验研究

    Transplantation of Autologous Bone Marrow Mesenchymal Stem Cells Transfected Ex Vivo by ANG or VEGF Gene in a Porcine Chronic Ischemic Heart Model

  16. 本文讨论了静止性卒中与高血压,缺血性心脏病及TIA发作持续时间的关系。

    The relation between silent stroke and hypertension , ischemic heart disease , and TIA was discussed .

  17. 结论:携带VEGF基因的自体骨髓基质细胞移植治疗缺血性心脏病具有明显的优越性,移植细胞成活率高,局部血?

    Conclusion : Transplantation of VEGF-transfected autologous marrow stromal cells has a high survival rate in the myocardium and can obviously improve blood supply and cardiac function .

  18. 调查者指出:缺血性心脏病的发生和抗CCP抗体的数量之间没有关系。

    " There was no relationship between ischemic heart disease and the quantity of anti-CCP antibodies ," the investigators note .

  19. 目的评价冠状动脉旁路移植术(冠脉搭桥术,CABG)治疗缺血性心脏病的临床效果。

    Objective To evaluate the CABG clinical results in treating ischaemic heart disease ( coronary artery disease , CAD ) .

  20. 结果:生脉注射液对缺血性心脏病患者心电图STT的改变有恢复作用(85%),并有一定的降血脂作用(P<0.05);

    Results : There was a restorative action for STT change ( 85 % ) and PL level was lower after treatment ( P < 0 05 ) .

  21. VEGF与甘油三酯、低密度脂蛋白、糖尿病视网膜病变、缺血性心脏病和闭塞性动脉硬化呈正相关,而与高密度脂蛋白呈负相关。

    Serum VEGF was positively correlated with triglyceride , low density lipoprotein , diabetic retinopathy , ischemic heart disease , and arteriosclerosis occlusion , but negatively correlated with high density lipoprotein .

  22. 动脉粥样硬化(Atherosclerosis,As)是严重危害人类健康的最主要疾患之一。它是缺血性心脏病和脑血管疾病的重要病理基础。

    Atherosclerosis ( AS ) is one of the main diseases threatening human health , what is more , AS is the important pathological basis of myocardial and cerebral vascular disordors .

  23. 多项研究已认为降低HDL(“好”胆固醇)会增加患缺血性心脏病的风险。

    A number of studies have tied low blood levels of HDL ( the " good " cholesterol ) to an increased risk of ischemic heart disease .

  24. 因此促进MSCs向CMs分化,提高其分化效率,是优化MSCs治疗缺血性心脏病迫切需要解决的问题。

    Therefore , promoting the differentiation of MSCs into myocardial cells and improving the efficiency are the urgent issues need to address for optimal treatment of ischemic heart disease .

  25. 并且有较高的发病率和死亡率。人们预测,到2020年,MD将成为仅次于缺血性心脏病的全球性第二大主要疾病。

    The morbidity of the disorder is high and has been projected to become the second leading cause of disability worldwide by 2020 ( second to ischemic heart disease ) .

  26. 结论:HMP是治疗缺血性心脏病心功能不全的一种有效而安全的药物。

    Conclusion : Heart-protecting musk pill is safe and effective to treat the cardiac dysfunction of ischemic heart disease .

  27. 国内外研究人员在缺血性心脏病的动物模型中研究证实,骨髓MSCs移植能再生有功能的心肌组织,改善其心功能,目前其可能的机制还不清。

    Researcher found that MSCs transplantation in ischemic heart diseases may regenerate functional myocardium within the infarcted region , and improve heart function . The mechanism of improving heart function was unclear .

  28. 目的探讨利用猪急性心肌梗死模型论证自体骨髓单个核细胞(BMMNCs)移植对缺血性心脏病的治疗潜能和安全性。

    Objective This preclinical study was designed using a swine model to investigate the safety and therapeutic potency of local bone marrow mononuclear cells ( BM MNCs ) implantation .

  29. 高脂血症是非胰岛素依赖型糖尿病(NIDDM)的常见并发症。由此并发症导致缺血性心脏病、脑血管疾病而危及生命者均不少见。

    Hyperlipoidemia , the common complication of non-insulin dependent diabetis mellitus ( NIDDM ) can result in ischemic heart disease and cerebrovascular disease which are life-threatening in many cases .

  30. 目的研究各种类型缺血性心脏病(IHD)患者血浆凝血因子Ⅶ(FⅦ)水平的改变并探讨其与血浆脂质的关系。

    Objective To study the variation and significance of plasma factor ⅶ( F ⅶ) in various types of ischemia heart disease ( IHD ) and discuss its relation with plasma lipid .